NEW YORK, March 8 (GenomeWeb News) - Acacia Research unit CombiMatrix has won a $5.9 million, two-year contract from the Department of Defense to develop microarray technology for the detection of biological weapons, the company said today.
Under the contract, which follows earlier funding from the DoD, CombiMatrix will develop an automated system for detecting potential biothreats, such as Bacillus anthracis, Yersinia pestis, and toxins.
CombiMatrix has already been collaborating with the U.S. Army Medial Research Institute of Infectious Disease since last year, under a Cooperative Research and Development Agreement, to integrate its technology into devices.